文献速递消化内镜消化道肿瘤与早癌

大型无蒂结直肠息肉:直肠与结肠黏膜下癌率及ESD结局比较

Rectal versus colonic submucosal cancer rates and procedural outcomes in large non-pedunculated polyps: French ESD registry data.
PubMed 文献 · Gut · 2025-10-12

基于法国ESD注册研究,纳入2019年9月至2022年9月13个中心的大型无蒂结直肠息肉,比较直肠与结肠的黏膜下浸润癌率及操作结局。经倾向评分匹配校正大小和形态后,直肠与结肠的黏膜下癌率无显著差异(9.8% vs 8.9%,p=0.52),整块切除和R0切除率相当,结肠并发症有升高趋势。结论提示应依据风险特征而非部位选择切除技术。

要点

  • 校正大小和形态后,直肠与结肠大型无蒂息肉的黏膜下癌率无显著差异。
  • 直肠与结肠ESD的整块切除和R0切除率相当。
  • 结肠ESD的穿孔和因并发症手术有非显著升高趋势。

核心结论

  • 大型无蒂息肉经校正大小和形态等因素后,直肠黏膜下浸润癌率不高于结肠。
  • 选择切除技术时应依据风险特征而非部位。
  • 直肠与结肠ESD的技术结局相当,结肠并发症有升高趋势。

研究设计与样本

  • 法国ESD注册研究,2019年9月至2022年9月13个中心纳入所有经ESD切除的大型无蒂息肉。
  • 共纳入3770个病变,分析3310个。
  • 采用倾向评分匹配和逆概率加权分析肿瘤学与操作结局,并对3个最大中心行亚组分析。

主要发现

  • 直肠病变更大(56.0(40;75)mm vs 47.0(37;62)mm),更常为颗粒型(80.0% vs 59.4%)和混合结节型(54.0% vs 32.5%)(p<0.001)。
  • 倾向评分匹配后,直肠与结肠病变的黏膜下癌率无显著差异(9.8% vs 8.9%,p=0.52)。
  • 整块切除率(97.7% vs 97.3%,p=0.757)和R0切除率(89.7% vs 89.5%,p=0.937)相当。
  • 穿孔(5.5% vs 7.9%,p=0.057)和因并发症手术(0.1% vs 1.1%,p=0.051)在结肠有非显著升高趋势。
  • 3个仅以ESD治疗此类息肉的中心亚组分析证实上述发现。

关键数值与推荐

  • 倾向评分匹配后黏膜下癌率:直肠9.8% vs 结肠8.9%(p=0.52)。
  • 整块切除率:直肠97.7% vs 结肠97.3%(p=0.757)。
  • R0切除率:直肠89.7% vs 结肠89.5%(p=0.937)。
  • 穿孔率:直肠5.5% vs 结肠7.9%(p=0.057)。
  • 因并发症手术率:直肠0.1% vs 结肠1.1%(p=0.051)。

临床怎么用

  • 对大型无蒂结直肠息肉,不应仅因位于直肠而默认选择ESD,应综合评估大小、形态等风险特征。
  • 直肠与结肠ESD的技术成功率相当,结肠操作时需更关注穿孔等并发症风险。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: For large non-pedunculated rectal polyps, en bloc resection via endoscopic submucosal dissection (ESD) is typically recommended due to presumed higher risk of submucosal invasive cancer (SMIC) compared with the colon; however, data on cancer risk by location remain controversial. OBJECTIVE: Using the French ESD registry, we compared SMIC rates in large non-pedunculated colorectal polyps in the rectum versus colon. Procedural outcomes were also compared. DESIGN: From September 2019 to September 2022, all large non-pedunculated polyps resected by ESD in 13 centres were included. Oncological and procedural outcomes were analysed using propensity score matching (PSM) and inverse probability weighting, accounting for relevant influencing factors. A subgroup analysis was performed on cases from the three largest centres, where such polyps were exclusively treated with ESD. RESULTS: Among 3770 lesions, 3310 were analysed. Rectal lesions were larger (56.0 (40; 75) mm vs 47.0 (37; 62) mm), more often granular (80.0% vs 59.4%) and mixed nodular (54.0% vs 32.5%) (p<0.001). After PSM, submucosal cancer rates were not significantly different between rectal and colonic lesions of similar size and morphology (9.8% vs 8.9%, p=0.52). En bloc (97.7% vs 97.3%, p=0.757) and R0 resection rates (89.7% vs 89.5%, p=0.937) were also comparable. Perforation (5.5% vs 7.9%, p=0.057) and surgery for complications (0.1% vs 1.1%, p=0.051) showed a non-significant trend towards higher rates in colonic procedures. Subgroup analysis from the three centres exclusively performing ESD for large non-pedunculated polyps confirmed these findings. CONCLUSION: In our multicentre registry, large non-pedunculated polyps do not show a higher prevalence of SMIC in the rectum compared with colon, when adjusted for relevant factors such as size and morphology. Therefore, risk features, rather than location, should guide the choice of resection technique. Technical outcomes were comparable between rectal and colonic ESD, with a trend for higher complication rates in the colon. TRIAL REGISTRATION NUMBER: NCT04592003.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Van der Voort V, Schaefer M, Wallenhorst T, et al. Rectal versus colonic submucosal cancer rates and procedural outcomes in large non-pedunculated polyps: French ESD registry data. Gut. 2025. PMID: 41083216. doi:10.1136/gutjnl-2024-332970

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。